vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and MDU RESOURCES GROUP INC (MDU). Click either name above to swap in a different company.

MDU RESOURCES GROUP INC is the larger business by last-quarter revenue ($522.6M vs $284.0M, roughly 1.8× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 14.6%, a 81.7% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -1.6%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -5.7%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

MDU Resources Group, Inc. is a U.S.-based corporation supplying products and services to regulated energy delivery and utilities related construction materials and services businesses. It is headquartered in Bismarck, North Dakota, and operates in 48 states.

ACAD vs MDU — Head-to-Head

Bigger by revenue
MDU
MDU
1.8× larger
MDU
$522.6M
$284.0M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+11.0% gap
ACAD
9.4%
-1.6%
MDU
Higher net margin
ACAD
ACAD
81.7% more per $
ACAD
96.3%
14.6%
MDU
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
-5.7%
MDU

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
MDU
MDU
Revenue
$284.0M
$522.6M
Net Profit
$273.6M
$76.3M
Gross Margin
90.8%
Operating Margin
6.1%
20.5%
Net Margin
96.3%
14.6%
Revenue YoY
9.4%
-1.6%
Net Profit YoY
90.3%
38.4%
EPS (diluted)
$1.61
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
MDU
MDU
Q4 25
$284.0M
$522.6M
Q3 25
$278.6M
$313.6M
Q2 25
$264.6M
$348.7M
Q1 25
$244.3M
$678.0M
Q4 24
$259.6M
$531.0M
Q3 24
$250.4M
$290.7M
Q2 24
$242.0M
$343.1M
Q1 24
$205.8M
$588.2M
Net Profit
ACAD
ACAD
MDU
MDU
Q4 25
$273.6M
$76.3M
Q3 25
$71.8M
$18.3M
Q2 25
$26.7M
$13.8M
Q1 25
$19.0M
$82.0M
Q4 24
$143.7M
$55.2M
Q3 24
$32.8M
$64.6M
Q2 24
$33.4M
$60.4M
Q1 24
$16.6M
$100.9M
Gross Margin
ACAD
ACAD
MDU
MDU
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Q1 24
88.8%
Operating Margin
ACAD
ACAD
MDU
MDU
Q4 25
6.1%
20.5%
Q3 25
12.8%
12.7%
Q2 25
12.2%
8.7%
Q1 25
7.9%
16.6%
Q4 24
59.1%
17.8%
Q3 24
12.6%
12.0%
Q2 24
12.6%
11.5%
Q1 24
7.4%
16.4%
Net Margin
ACAD
ACAD
MDU
MDU
Q4 25
96.3%
14.6%
Q3 25
25.8%
5.8%
Q2 25
10.1%
4.0%
Q1 25
7.8%
12.1%
Q4 24
55.4%
10.4%
Q3 24
13.1%
22.2%
Q2 24
13.8%
17.6%
Q1 24
8.0%
17.2%
EPS (diluted)
ACAD
ACAD
MDU
MDU
Q4 25
$1.61
$0.37
Q3 25
$0.42
$0.09
Q2 25
$0.16
$0.07
Q1 25
$0.11
$0.40
Q4 24
$0.86
$0.26
Q3 24
$0.20
$0.32
Q2 24
$0.20
$0.30
Q1 24
$0.10
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
MDU
MDU
Cash + ST InvestmentsLiquidity on hand
$177.7M
$28.2M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$1.2B
$2.8B
Total Assets
$1.6B
$7.6B
Debt / EquityLower = less leverage
0.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
MDU
MDU
Q4 25
$177.7M
$28.2M
Q3 25
$258.0M
$75.9M
Q2 25
$253.6M
$58.8M
Q1 25
$217.7M
$59.5M
Q4 24
$319.6M
$66.9M
Q3 24
$155.1M
$88.3M
Q2 24
$177.1M
$78.8M
Q1 24
$204.7M
$72.7M
Total Debt
ACAD
ACAD
MDU
MDU
Q4 25
$2.7B
Q3 25
$2.4B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Q1 24
$2.3B
Stockholders' Equity
ACAD
ACAD
MDU
MDU
Q4 25
$1.2B
$2.8B
Q3 25
$917.3M
$2.7B
Q2 25
$822.4M
$2.7B
Q1 25
$765.2M
$2.7B
Q4 24
$732.8M
$2.7B
Q3 24
$577.2M
$3.1B
Q2 24
$516.7M
$3.0B
Q1 24
$464.0M
$3.0B
Total Assets
ACAD
ACAD
MDU
MDU
Q4 25
$1.6B
$7.6B
Q3 25
$1.3B
$7.2B
Q2 25
$1.2B
$6.9B
Q1 25
$1.1B
$7.0B
Q4 24
$1.2B
$7.0B
Q3 24
$976.9M
$8.2B
Q2 24
$914.1M
$8.0B
Q1 24
$855.1M
$7.8B
Debt / Equity
ACAD
ACAD
MDU
MDU
Q4 25
0.97×
Q3 25
0.86×
Q2 25
0.80×
Q1 25
0.80×
Q4 24
0.85×
Q3 24
0.76×
Q2 24
0.75×
Q1 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
MDU
MDU
Operating Cash FlowLast quarter
$-48.7M
$80.6M
Free Cash FlowOCF − Capex
$-336.0M
FCF MarginFCF / Revenue
-64.3%
Capex IntensityCapex / Revenue
79.7%
Cash ConversionOCF / Net Profit
-0.18×
1.06×
TTM Free Cash FlowTrailing 4 quarters
$-297.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
MDU
MDU
Q4 25
$-48.7M
$80.6M
Q3 25
$74.3M
$57.9M
Q2 25
$64.0M
$117.4M
Q1 25
$20.3M
$217.5M
Q4 24
$40.4M
$60.5M
Q3 24
$63.2M
$140.2M
Q2 24
$25.0M
$136.5M
Q1 24
$29.1M
$165.1M
Free Cash Flow
ACAD
ACAD
MDU
MDU
Q4 25
$-336.0M
Q3 25
$73.9M
$-121.9M
Q2 25
$36.5M
Q1 25
$124.4M
Q4 24
$-95.8M
Q3 24
$63.2M
$673.0K
Q2 24
$26.5M
Q1 24
$48.1M
FCF Margin
ACAD
ACAD
MDU
MDU
Q4 25
-64.3%
Q3 25
26.5%
-38.9%
Q2 25
10.5%
Q1 25
18.4%
Q4 24
-18.0%
Q3 24
25.2%
0.2%
Q2 24
7.7%
Q1 24
8.2%
Capex Intensity
ACAD
ACAD
MDU
MDU
Q4 25
79.7%
Q3 25
0.1%
57.3%
Q2 25
23.2%
Q1 25
13.7%
Q4 24
29.4%
Q3 24
0.0%
48.0%
Q2 24
32.0%
Q1 24
19.9%
Cash Conversion
ACAD
ACAD
MDU
MDU
Q4 25
-0.18×
1.06×
Q3 25
1.03×
3.16×
Q2 25
2.40×
8.52×
Q1 25
1.07×
2.65×
Q4 24
0.28×
1.10×
Q3 24
1.93×
2.17×
Q2 24
0.75×
2.26×
Q1 24
1.76×
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

MDU
MDU

Natural Gas Distribution$382.8M73%
Commercial Utility Sales$42.7M8%
Residential Utility Sales$33.7M6%
Pipelineand Midstream$31.1M6%
Natural Gas Transportation$17.2M3%
Industrial Utility Sales$10.1M2%
Natural Gas Storage$6.4M1%
Other Utility Sales$1.9M0%

Related Comparisons